$XXII “Ultimate Stock Alerts” Promoter Rank: 22/22 22nd Century Group, Inc. Newsletter 7:35:52 AM May 13, 2022

on May 13, 2022 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Ultimate Stock Alerts"

The following three charts can be used by potential investors to gauge the performance of "Ultimate Stock Alerts":


2 out of 7 campaigns closed down on first day


2 out of 7 campaigns closed up on first day


3 out of 7 campaigns had no net effect

XXII Promotional Newsletter

The following is a newsletter released by "Ultimate Stock Alerts" promoting 22nd Century Group, Inc.


The following newsletter has not been verified for accuracy or completeness.


Don't Want Anymore Emails


New Alert 22nd Century Group, Inc. NASDAQ XXII

XXII is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content RNC tobacco plants and cigarettes, which have become the cornerstone of the FDAs Comprehensive Plan to address the widespread death and disease caused by smoking.

XXII received the first and only FDA MRTP authorization of a combustible cigarette in December 2021.

As the company recently explained

VLN is the first cigarette in the world that is not designed to create or sustain nicotine addiction.

VLN smokes, smells, and tastes like a conventional cigarette, but uses 22nd Century Groups proprietary tobacco to deliver Americas lowest nicotine content cigarette with 95% less nicotine than Americas leading brands.

The Company launched VLN, the first cigarette that Helps You Smoke Less, in the Chicago metro area in April 2022.


VLN King and VLN Menthol King are the only FDA authorized reduced nicotine content combustible cigarettes in the U.S. tobacco products market, estimated at approximately $80 billion in size. Menthol cigarettes make up nearly 40% of the U.S. cigarette market.

Additionally, as the company stated in a recent press release

The proprietary tobacco was the subject of 10 years of research and more than 50 government-funded, independent clinical trials. The research was conducted by or for esteemed public health institutions and universities, including the FDA the National Institute on Drug Abuse NIDA Centers for Disease Control and Prevention CDC the National Cancer Institute NCI Johns Hopkins University and Mayo Clinic, to name a few.

According to the American Lung Association, smoking is the number one preventable cause of death in the U.S., killing over 480,000 people per year.

Despite this, the popularity of these products has been growing.

From 2019 to 2021, disposable e-cigarette use skyrocketed by more than 23 times among high school e-cigarette users from 2.4% to 55.8% and more than 14 times among middle school e-cigarette users from 3% to 43.8%.

Furthermore, More than 23.6% of high school students in the U.S. use at least one tobacco product, including e-cigarettes, according to the 2020 National Youth Tobacco Survey.

Companies like XXII could be on the frontlines of the much-needed change.

Over the past few months, the company has announced multiple accomplishments.

Earlier this year, the company announced

22nd Century Group Announces South Korea as First VLN International Market

Here are the companys comments from this press release

South Korea is an ideal international launch market in many ways, with a high smoking rate among developed countries and a government strongly committed to smoking harm reduction. We expect the first sale of VLN reduced nicotine content cigarettes to our South Korean partner to occur by the end of March, said James A. Mish, Chief Executive Officer.


The Company will continue its launch process in additional markets in Asia and Europe with limited regulatory barriers while also leveraging VLNs MRTP authorization toward seeking approval in additional markets with higher regulatory barriers.

In April, the company announced

First Cigarette That Helps You Smoke Less Launches National Pilot in Chicagoland

Here are some of the companys comments from this press release

The three- to six-month pilot will be the first U.S. sales of VLN King and VLN Menthol King cigarettes. 22nd Century is also launching VLN cigarettes in South Korea, its first international market. Following the pilot, 22nd Century and Circle K intend to expand sales nationwide to more than 7,000 stores in 48 states.

In addition, the company also announced

22nd Century Group Nasdaq XXII Expects VLN Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDAs Proposed Ban on Menthol Cigarettes

BUFFALO, N.Y., April 29, 2022 GLOBE NEWSWIRE -- 22nd Century Group, Inc. Nasdaq XXII, a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its support of FDAs plan to ban menthol in all cigarettes and that the Company expects VLN Menthol King reduced nicotine cigarettes to be exempted from FDAs menthol ban under procedures detailed in FDAs proposed rule announced April 28, 2022.

We commend the FDA for taking action to reduce tobacco-related disease and death and advance health equity. Todays proposed menthol ban is expected to have enormous health benefits for the nearly 18.6 million current smokers of menthol cigarettes including the millions of African-Americans who are disproportionally harmed by these products, said James A. Mish, chief executive officer of 22nd Century Group.

Here are some of the companys additional comments from this press release

John Pritchard, Vice President of Regulatory Science for 22nd Century added, Removing menthol from highly addictive cigarettes is a crucial public health step by the FDA, and we welcome todays announcement. At the same time, we recognize, as the FDA has, that many adults who continue to smoke highly addictive cigarettes after the implementation of a final FDA rule will need access to suitably regulated alternative products. Our VLN products, including our recently authorized MRTP VLN Menthol King is an example of such a product, and we have already and will continue to represent our views to FDA on the importance of MRTP products in achieving FDAs public health mission.

Most recently, the company announced

22nd Century Group Nasdaq XXII Reports Business Highlights and Financial Results for the First Quarter 2022

Here are the highlights from this press release

Launched VLN Pilot Program in Chicago with Circle K as First Retail Trade Partner

Began VLN Shipments to South Korea for First International Launch

FDAs Proposed Menthol Ban Could Leave VLN Menthol King as the Only Menthol Cigarette on the Market

Achieved Breakthrough in HempCannabis Plant Transformation Technology

First Quarter Net Sales $9.0 million, up 33% Year-Over-Year

Here are some of the companys comments from this announcement

We are particularly excited to partner with Circle K, the second largest convenience store chain in the U.S., as our lead channel partner in bringing these products to market.

VLN is featured prominently in Circle Ks stores where we are testing a variety of point-of-sale marketing materials and promotional programs to build awareness about VLN and its unique benefits for adult smokers, 70% of whom want to quit smoking.

In addition

As we look to expand VLN marketing and distribution beyond Chicago, we have already secured regulatory clearances to sell in 9 states and have applications pending in all other U.S. states. Additionally, we are engaged in discussions with a number of national and regional channel partners who recognize the exciting potential of VLN and want to offer it to their customers.

As the company further explains

VLN is now available at more than 150 Chicago-area Circle K retail stores in a pilot designed to optimize 22nd Centurys marketing programs.

Ahead of its planned national VLN launch, 22nd Century has secured the regulatory authorizations to sell VLN in 9 states to date Illinois, California, New York, Colorado, Texas, Florida, Minnesota, Mississippi and Rhode Island.

XXII could be in a position to experience increased growth.

Make sure to do your own due diligence.

Sources , , , , , , , , , , ,

Happy Trading


Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.



You should read and understand this disclaimer in its entirety before joining the website or emailblog list of UltimateStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

Owners and operators of the Publisher expect to be compensated twelve thousand five hundred dollars by bank wire transfer on 51322 for the distribution of this advertisement about XXII dated 51322. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 82321 for the distribution of a prior advertisement about XXII. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 62521 for the distribution of a prior advertisement about XXII. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about XXII. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.

You are receiving this reportrelease because you subscribed to receive it at our website or through a third-party site. All our newsletters include an unsubscribe link, and you can remove yourself at any time from our newsletters by clicking on that unsubscribe link. You can also contact us at infoUltimateStockAlerts.com to change your information at any time. By your subscription to our profiles, the viewing of this profile andor use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link

www.UltimateStockAlerts.comDisclaimer and www.UltimateStockAlerts.comPrivacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.

Our records indicate that . requested and confirmed to be added to UltimateStockAlerts.com on January 26, 2015.

6020 Bent Pine Dr, Orlando, FL 32822, USA

Last 1 Stock Promotions By "Ultimate Stock Alerts"

Symbol Company Start Date Close Change
PURE PURE Bioscience May 11, 2022 0.166 -7%